Skip to main content

Loumeau Eric J's Form 4 filing

Anaptysbio, Inc (ANAB) · filed Jan 8, 2026

Accession no.
0001239648-26-000004
Filed
Jan 8, 2026
Trade date
Jan 6-7, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $439.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Loumeau Eric JCIK 0001239648Officer (CHIEF LEGAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 6, 2026Common StockMOption exerciseAcquired+5,545––18,796Direct
Jan 7, 2026Common StockSSaleDisposed−2,017$45.11−$90,986.8716,779Direct
Jan 7, 2026Common StockSSaleDisposed−5,281$45.38−$239,651.7811,498Direct
Jan 7, 2026Common StockSSaleDisposed−1,841$46.13−$84,925.339,657Direct
Jan 7, 2026Common StockSSaleDisposed−500$47.23−$23,6159,157Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 6, 2026Common StockMOption exerciseDisposed−5,545$0.00$05,545Direct
Jan 6, 2026Common StockAGrant or awardAcquired+17,100$0.00$017,100Direct
Jan 6, 2026Common StockAGrant or awardAcquired+23,200$0.00$023,200Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)